Drugmakers face down deadline on Medicare price negotiations

The deadline for drugmakers to sign agreements to negotiate with Medicare on pricing is fast approaching. Major drugmakers have until Sunday to sign an agreement to participate in the program or potentially face heavy taxes and lose their ability to sell through Medicare. With courts yet to impose an injunction in a spate of pending…

Related Keywords

United States ,Americans ,Bristol Myers Squibb ,Michaelj Newman ,Jack Hoadley ,Novartis ,Medicare Drug Price Negotiation Program ,Centers For Medicare Medicaid Services ,Novo Nordisk ,Human Services ,Astrazeneca ,Department Of Health ,Boehringer Ingelheim ,Immunex Corporation ,Johnson ,Medicaid Services ,Inflation Reduction Act ,Judge Michael ,Health Policy Institute ,Georgetown University ,Mccourt School ,Public Policy ,Medicare ,Medicaid ,Companies ,Drugmakers ,